OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
Hong Zheng, Yunlong Cao, Xiaosu Chen, et al.
Cell Research (2022) Vol. 32, Iss. 8, pp. 781-784
Open Access | Times Cited: 29
Hong Zheng, Yunlong Cao, Xiaosu Chen, et al.
Cell Research (2022) Vol. 32, Iss. 8, pp. 781-784
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 593-602
Open Access | Times Cited: 1195
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 593-602
Open Access | Times Cited: 1195
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 144
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 144
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 78
Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 78
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection
Hong Wang, Cuicui Liu, Xiaowei Xie, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1410-1428.e8
Open Access | Times Cited: 27
Hong Wang, Cuicui Liu, Xiaowei Xie, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1410-1428.e8
Open Access | Times Cited: 27
Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey
Shijie Qin, Yanhua Li, Likui Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 18
Shijie Qin, Yanhua Li, Likui Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 18
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
Xiaosu Chen, Yanli Xu, Yan Xie, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 33, pp. 100758-100758
Open Access | Times Cited: 16
Xiaosu Chen, Yanli Xu, Yan Xie, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 33, pp. 100758-100758
Open Access | Times Cited: 16
Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Xiaolu Zhu, Qian Jiang, Jin Lu, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 1, pp. 31-39
Open Access | Times Cited: 12
What is the role of aerosol transmission in SARS-Cov-2 Omicron spread in Shanghai?
Gui‐Quan Sun, Xia Ma, Zhenzhen Zhang, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Gui‐Quan Sun, Xia Ma, Zhenzhen Zhang, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents
Zhiqing Li, Xiaosu Chen, Junyan Dan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Zhiqing Li, Xiaosu Chen, Junyan Dan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
‘Dynamic zero-COVID’ policy and viral clearance during an omicron wave in Tianjin, China: a city-wide retrospective observational study
Yahui Feng, Hongxia Shao, Xiaowen Gong, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e066359-e066359
Open Access | Times Cited: 12
Yahui Feng, Hongxia Shao, Xiaowen Gong, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e066359-e066359
Open Access | Times Cited: 12
Comparative Analysis of Clinical and CT Findings in Patients with SARS-CoV-2 Original Strain, Delta and Omicron Variants
Xiaoyu Han, Jingze Chen, Lu Chen, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 901-901
Open Access | Times Cited: 7
Xiaoyu Han, Jingze Chen, Lu Chen, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 901-901
Open Access | Times Cited: 7
The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
Min Shen, Ping Ding, Guangxin Luan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Min Shen, Ping Ding, Guangxin Luan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children’s medical center in Shanghai, China
Nan Shen, Yufen Wu, Yiwei Chen, et al.
World Journal of Pediatrics (2022) Vol. 19, Iss. 1, pp. 87-95
Open Access | Times Cited: 9
Nan Shen, Yufen Wu, Yiwei Chen, et al.
World Journal of Pediatrics (2022) Vol. 19, Iss. 1, pp. 87-95
Open Access | Times Cited: 9
BF.7: a new Omicron subvariant characterized by rapid transmission
Xiaoyu Gao, Furong Wang, Liu Hui-zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 1, pp. 137-141
Open Access | Times Cited: 3
Xiaoyu Gao, Furong Wang, Liu Hui-zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 1, pp. 137-141
Open Access | Times Cited: 3
Evidence of the Efficacy and the Effectiveness of First Generation COVID-19 Vaccines in Clinical Trials and Real-world Studies
Jingxin Li, Zhuopei Li, Yawen Zhu, et al.
Zoonoses (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Jingxin Li, Zhuopei Li, Yawen Zhu, et al.
Zoonoses (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
Xiaosu Chen, Yanli Xu, Yan Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Xiaosu Chen, Yanli Xu, Yan Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study
Fuying Gu, Huiying Lin, Zhenqiang Chen, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 987-987
Open Access | Times Cited: 2
Fuying Gu, Huiying Lin, Zhenqiang Chen, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 987-987
Open Access | Times Cited: 2
Low risk of relapse in aplastic anemia patients after SARS‐CoV ‐2 omicron infection: A prospective NICHE cohort
Lele Zhang, Jingyu Zhao, Ruonan Li, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10
Open Access | Times Cited: 2
Lele Zhang, Jingyu Zhao, Ruonan Li, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10
Open Access | Times Cited: 2
Metabolic Syndrome Is Associated with Poor Omicron Infection Prognosis While Inactivated Vaccine Improves the Outcome of Coronavirus Disease 2019 among Chinese Inhabitants: A Retrospective Observational Study from a Chinese Municipality
Ying Liu, Dong Chen, Junfeng Li, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1554-1554
Open Access | Times Cited: 2
Ying Liu, Dong Chen, Junfeng Li, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1554-1554
Open Access | Times Cited: 2
A booster shot of vaccine against SARS-CoV-2 should be rigorously promoted and implemented in China
Yong Yin, Jilei Lin, Shuhua Yuan, et al.
Journal of Infection (2022) Vol. 86, Iss. 2, pp. e49-e50
Open Access | Times Cited: 4
Yong Yin, Jilei Lin, Shuhua Yuan, et al.
Journal of Infection (2022) Vol. 86, Iss. 2, pp. e49-e50
Open Access | Times Cited: 4
The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthrough infection
Ni Wang, Huimin Fan, Yixuan Wang, et al.
Life Sciences (2024) Vol. 358, pp. 123197-123197
Closed Access
Ni Wang, Huimin Fan, Yixuan Wang, et al.
Life Sciences (2024) Vol. 358, pp. 123197-123197
Closed Access
Waning of post-vaccination neutralizing antibody responses against SARS-CoV-2, a systematic literature review and meta-analysis
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
